While further research is required to explore whether the degree of “fatness” impacts the effectiveness of exercise on clinical markers of NAFLD, it has been recognized that weight loss is associated with important pathophysiological changes, specifically increased insulin sensitivity, decreased fatty acids in the liver, decreased inflammatory mechanisms, and improved levels of ALT and AST enzymes [56]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.